National Amyotrophic Lateral Sclerosis (ALS) Biorepository’s Augmentation of ALS Samples for Researchers through an Established External Repository

SOL #: 0HJAAQBE-2025-94961Sources SoughtSole Source

Overview

Buyer

Health And Human Services
Centers For Disease Control And Prevention
CDC OFFICE OF ACQUISITION SERVICES
ATLANTA, GA, 30333, United States

Place of Performance

Atlanta, GA

NAICS

No NAICS code specified

PSC

No PSC code specified

Set Aside

No set aside specified

Timeline

1
Posted
Apr 2, 2026
2
Response Deadline
Apr 7, 2026, 5:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm fixed-price contract to Temple University ALS Postmortem Core for the National Amyotrophic Lateral Sclerosis (ALS) Biorepository’s Augmentation of ALS Samples for Researchers. This effort aims to advance ALS research by providing high-quality samples. Responses from interested contractors are due by April 7, 2026, 1:00 PM ET.

Scope of Work

The Government seeks a nationally recognized tissue core repository to facilitate and provide ALS samples and data for research into risk factors, genetics, biomarkers, and etiologies. The contractor must have extensive experience in providing tissue samples to academic and industry laboratories worldwide. Key requirements for the repository include:

  • Frozen and fixed CNS tissues, liver, and various muscles from ALS/MND and non-neurologic control autopsies.
  • Standard Operating Procedures (SOPs) optimized for tissue dissection, processing, QC analysis, clinical data elements, and neuropathological characterization for ALS researchers.
  • Dissection methods that maximize individual, optimally sized tissue samples while preserving tissue architecture.
  • A large collection of ALS samples from the Guam cluster.

Contract & Timeline

  • Type: Sole Source (Firm Fixed Price) - Notice of Intent to Sole Source
  • Authority: FAR 6.103-1 and 41 U.S.C. § 3304(a)(1)
  • Duration: May 1, 2026 – April 30, 2027, with four one-year option periods.
  • Set-Aside: None specified (sole source)
  • Response Due: April 7, 2026, 1:00 PM ET
  • Published: April 2, 2026

Evaluation

This notice is not a request for competitive quotations. However, interested contractors may identify their interest and capability to respond. Responses will be considered solely to determine if a competitive procurement is feasible. Insufficient information regarding capability will result in the response not being considered.

Additional Notes

The Government's determination not to compete this proposed contract is at its sole discretion.

People

Points of Contact

Taylor WellmanPRIMARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Sources Sought
Posted: Apr 2, 2026
National Amyotrophic Lateral Sclerosis (ALS) Biorepository’s Augmentation of ALS Samples for Researchers through an Established External Repository | GovScope